Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The myotonic dystrophy gene

A Pizzuti1, D L Friedman, C T Caskey

  • 1Institute for Molecular Genetics, Baylor College of Medicine, Houston, Tex.

Archives of Neurology
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Array-comparative genomic hybridization analysis in a cohort of 130 children with Autism Spectrum Disorders: A single Center Italian Study.

La Clinica terapeutica·2023
Same author

Single-nucleotide polymorphisms in 3'-untranslated region inducible costimulator gene and the important roles of miRNA in alopecia areata.

Skin health and disease·2022
Same author

Androgen insensitivity syndrome.

European review for medical and pharmacological sciences·2018
Same author

MRI and US in the evaluation of fetal anomalies: The need to work together.

Prenatal diagnosis·2017
Same author

Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2013
Same author

Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata.

Clinical and experimental medicine·2012
Same journal

Incorrect Table Entries and Word.

Archives of neurology·2016
Same journal

IDEAL for CCSVI Research-Reply.

Archives of neurology·2013
Same journal

Atlas of Inherited Metabolic Diseases, 3rd ed.

Archives of neurology·2013
Same journal

Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

Archives of neurology·2013
Same journal

This month in archives of neurology.

Archives of neurology·2013
Same journal

About this journal.

Archives of neurology·2013
See all related articles

Myotonic dystrophy is caused by expanded (adenine-guanine-cytosine) [AGC] repeats in a gene. Larger repeat sizes correlate with increased disease severity, aiding diagnosis and genetic counseling.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Myotonic dystrophy is a genetic disorder affecting muscle function.
  • The gene responsible for myotonic dystrophy encodes a protein kinase.
  • This gene contains a polymorphic trinucleotide repeat motif (adenine-guanine-cytosine [AGC]).

Purpose of the Study:

  • To investigate the role of AGC repeat expansions in myotonic dystrophy.
  • To establish the correlation between repeat size and clinical severity.
  • To evaluate the diagnostic utility of direct AGC repeat size analysis.

Main Methods:

  • Analysis of the trinucleotide repeat size in the myotonic dystrophy gene.
  • Comparison of repeat sizes in normal individuals versus patients.

Related Experiment Videos

  • Correlation analysis between repeat size and clinical severity scores.
  • Main Results:

    • Normal alleles exhibit 5 to 37 AGC units.
    • Myotonic dystrophy patients display expanded repeats, ranging from over 50 to several thousand units.
    • A positive correlation was observed between the size of the AGC repeat expansion and the clinical severity of the disease.

    Conclusions:

    • Expanded AGC trinucleotide repeats are the molecular basis of myotonic dystrophy.
    • Repeat size is a key determinant of disease severity.
    • Direct analysis of AGC repeat size provides a reliable method for confirming myotonic dystrophy diagnosis and for prenatal genetic counseling.